Jenburkt Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

67.46

66.98

61.29

62.69

47.92

Operating profit

16.07

15.89

11.63

15.63

7.80

Interest

0.14

0.18

0.22

0.21

0.24

Gross profit

18.06

18.11

13.97

17.80

9.56

EPS (Rs)

28.76

27.93

21.08

27.50

14.56

Other income

2.13

2.40

2.56

2.39

2.00

Stock adjustment

-1.31

-1.13

-2.54

0.25

-1.35

Raw material

3.72

5.57

6.31

5.43

2.92

Power and fuel

-

-

-

-

-

Employee expenses

20.55

19.24

18.73

17.76

16.02

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

28.42

27.41

27.17

23.61

22.53

Provisions made

-

-

-

-

-

Depreciation

1.09

1.08

1.01

0.89

1.00

Taxation

4.28

4.21

3.28

4.29

1.88

Net profit / loss

12.69

12.82

9.68

12.62

6.68

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

4.41

4.59

4.59

4.59

4.59

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

23.82

23.72

18.97

24.93

16.28

GPM (%)

25.95

26.10

21.87

27.36

19.16

NPM (%)

18.23

18.47

15.15

19.40

13.38